Literature DB >> 33636821

High-Throughput LC-MS/MS Method for Determination of the Alcohol Use Biomarker Phosphatidylethanol in Clinical Samples by Use of a Simple Automated Extraction Procedure-Preanalytical and Analytical Conditions.

Anders Isaksson1, Lisa Walther1, Therese Hansson1, Anders Andersson1, Joanna Stenton1, Anders Blomgren1.   

Abstract

BACKGROUND: Phosphatidylethanol (PEth) is an alcohol use biomarker with higher clinical sensitivity and specificity than commonly used alcohol markers. Since its introduction as a clinical alcohol-marker in 2006, the number of samples sent to our laboratory for the determination of PEth has shown a strong annual increase. This has prompted the need to develop a cost-effective and reliable analytical procedure with high capacity.
METHODS: An LC-MS/MS method for the determination of PEth 16:0/18:1 with a short turnaround time (3 min) has been evaluated with respect to accuracy, sensitivity, and precision. We compared this method with a previously used HPLC method, as well as a manual and a simplified automated method for sample workup, and investigated potential causes of analytic and preanalytic errors.
RESULTS: The method shows limits of detection and quantification of 0.0075 μmol/L (5.2 ng/mL) and <0.05 μmol/L (<35 ng/mL), respectively. During a 2.1-year period, the method has shown a total CV < 8% for control samples (n = 2808) in the range of 0.10 (70) to 3.5 μmol/L (2461 ng/mL). The simplified automated method for sample preparation works equally well as the manual one. No specific and clinically significant causes of preanalytic errors were found.
CONCLUSIONS: This LC-MS/MS method with automated sample workup is well suited for a clinical laboratory with LC-MS/MS experience and has the capability, proven from several years of use, to produce reliable PEth results in a high-volume laboratory (>50000 clinical samples/year).
© 2017 American Association for Clinical Chemistry.

Entities:  

Year:  2018        PMID: 33636821     DOI: 10.1373/jalm.2017.024828

Source DB:  PubMed          Journal:  J Appl Lab Med        ISSN: 2475-7241


  2 in total

1.  Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of Differences Between Alcohol-Related and Non-Alcohol-Related Cirrhosis Candidates.

Authors:  Jan-Paul Gundlach; Felix Braun; Finn Mötter; Alexander Bernsmeier; Pablo Barrio; Nicola Ehmke; Rainer Günther; Holger Hinrichsen; Thomas Becker; Wolfgang Weinmann; Alexandra Schröck; Michel Yegles; Friedrich Martin Wurst
Journal:  Ann Transplant       Date:  2022-06-07       Impact factor: 1.479

2.  Secondary Analysis of a Randomized Clinical Trial of Naltrexone Among Women Living With HIV: Correlations Between Reductions in Self-Reported Alcohol Use and Changes in Phosphatidylethanol.

Authors:  Veronica L Richards; Ruba Sajdeya; Karina Villalba; Yan Wang; Vaughn Bryant; Babette Brumback; Kendall Bryant; Judith A Hahn; Robert L Cook
Journal:  Alcohol Clin Exp Res       Date:  2020-12-17       Impact factor: 3.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.